Having antibodies diverse enough to neutralize a range of viruses is advantageous for preventing reinfection. But the molecular features that underlie this diversity (and how it is generated) are poorly understood. James Crowe, Jr., M.D., and colleagues previously isolated an antibody to 1918 influenza (called 2D1) that could also neutralize the 2009 H1N1 strain. In […]
The Vanderbilt-Ingram Cancer Center is joining with national and local partners to offer AWARE for All – Nashville Clinical Research Education Day on Saturday, Feb. 20.
This event, which is free and open to the public, is believed to be the first community-wide event designed to inform Middle Tennessee residents about the important role that they can play in making medical advances possible and to celebrate the contributions of clinical research participants in moving science forward.